Regoval Co 80/12,5 mg,160/12,5 mg,160/25 mg FC tablets.
PDF Leaflet Revision Date: 11 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension.
Dosage (summary)
1 tablet daily; max 320/25 mg once daily.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Lithium
- Potassium-sparing diuretics
- Fluoroquinolones
Contraindications
- Hypersensitivity to valsartan or hydrochlorothiazide
- Severe renal impairment
- Severe hepatic impairment
Common side effects
- Hypotension
- Dizziness
- Hyperkalaemia
Counselling Points
- Take with water
- Monitor blood pressure
- Avoid potassium supplements
Serious warnings
- Risk of angioedema
- Photosensitivity
- Non-melanoma skin cancer risk
Important Disclaimer
The Regoval Co 80/12,5 mg,160/12,5 mg,160/25 mg FC tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
